EHTH vs. MMC, AON, AJG, BRO, SLQT, TWFG, WDH, GOCO, RDZN, and AIFU
Should you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), SelectQuote (SLQT), TWFG (TWFG), Waterdrop (WDH), GoHealth (GOCO), Roadzen (RDZN), and AIX (AIFU). These companies are all part of the "insurance agents, brokers, & service" industry.
eHealth vs.
eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MMC) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings, community ranking and media sentiment.
Marsh & McLennan Companies has a net margin of 16.82% compared to eHealth's net margin of -7.58%. Marsh & McLennan Companies' return on equity of 32.65% beat eHealth's return on equity.
eHealth has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Marsh & McLennan Companies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.
79.5% of eHealth shares are held by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are held by institutional investors. 4.1% of eHealth shares are held by insiders. Comparatively, 0.3% of Marsh & McLennan Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.
In the previous week, Marsh & McLennan Companies had 9 more articles in the media than eHealth. MarketBeat recorded 16 mentions for Marsh & McLennan Companies and 7 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.11 beat eHealth's score of 0.77 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.
Marsh & McLennan Companies received 22 more outperform votes than eHealth when rated by MarketBeat users. Likewise, 61.81% of users gave Marsh & McLennan Companies an outperform vote while only 61.76% of users gave eHealth an outperform vote.
eHealth currently has a consensus price target of $6.38, indicating a potential downside of 17.21%. Marsh & McLennan Companies has a consensus price target of $228.13, indicating a potential upside of 7.01%. Given Marsh & McLennan Companies' higher possible upside, analysts plainly believe Marsh & McLennan Companies is more favorable than eHealth.
Summary
Marsh & McLennan Companies beats eHealth on 16 of the 18 factors compared between the two stocks.
Get eHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:EHTH) was last updated on 12/18/2024 by MarketBeat.com Staff
